Comparison

Dibenz[a,h]anthracene European Partner

Item no. HY-W013053-25mg
Manufacturer MedChem Express
CASRN 53-70-3
Amount 25 mg
Specific against other
Purity 98.0
Citations [1]Amal I Malik, et al. Hepatic genotoxicity and toxicogenomic responses in Muta™Mouse males treated with dibenz[a,h]anthracene. Mutagenesis. 2013 Sep;28(5):543-54.<br>[2]K L Platt, et al.  Stereoselective metabolism of dibenz(a,h)anthracene to trans-dihydrodiols and their activation to bacterial mutagens. Environ Health Perspect. 1990 Aug:88:37-41.
Alias DBA; 1,2,5,6-Dibenzanthracene; Benzo[k]tetraphene
Available
Product Description
Dibenz[a, h]anthracene (DBA) is a polycyclic aromatic hydrocarbon (PAH) of considerable tumorigenicity. Dibenz[a, h]anthracene results in DNA adduct formation leading to the activation of a DNA damage response. Dibenz[a, h]anthracene induces cell cycle arrest and apoptosis via both Tp53-dependent and Tp53-independent mechanisms[1][2].
StorageTemperature
-20°C, 3 years; 4°C, 2 years (Powder)
Shipping
Room Temperature
Manufacturers Applications
Cancer-programmed cell death
MolecularWeight
278.35
Clinical_Information
Phase 3
Manufacturers Research_Area
Cancer
Solubility
10 mM in DMSO
Manufacturers Target
Apoptosis; DNA/RNA Synthesis; MDM-2/p53
Pathway
Apoptosis; Cell Cycle/DNA Damage
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 25 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close